Cochlear Americas announces the commercial launch of the Nucleus 6 system on September 30th, 2013. In the interim, there will be a Technology Exchange Program for anyone who chooses a Cochlear System today. The program allows new Nucleus 5 recipients to exchange their Nucleus 5 Sound Processor(s) for Nucleus 6 Sound Processor(s) at no additional cost upon availability of the product.
More details here.
In a continuation of the global rollout of the Nucleus 6 system, Cochlear announces CE Mark approval.
When the wireless features are enabled, they will take advantage of the Gn ReSound Unite Phone Clip + or a similar device for Bluetooth connectivity.
MED-EL recently rolled out the RONDO processor. Cochlear has just received FDA approval for the Nucleus 6. And AB is awaiting FDA approval for the Naída CI. Why isn’t the new hardware available as soon as it has been approved?
Two executives from Advanced Bionics offer some insight into the process of launching a new product, including the risks and challenges of getting the product to market as soon as possible.
Read more here.
Cochlear has received FDA approval for the Nucleus 6 system!
FDA approval page
The Nucleus 6 processors are available in Canada! More information here.
The Nucleus 6 has received regulatory approval in Korea and Canada. For the full update, see the press release.
The Nucleus® 6 System is our most advanced hearing solution to date, designed with a clear purpose – to help you simply enjoy smarter hearing.
The announcement doesn’t say when the processor will be available. It is awaiting FDA approval in the US. Key features of the processor include combined electro-acoustic stimulation, and wireless connectivity (when the accessories become available).
Learn more here!
Nucleus 6 User Guide
Once again, CochlearimplantHELP.com delivers spy images of a new product! The CP900 series from Cochlear, dubbed Nucleus 6 on various web forums, seems to come in two sizes. The image shows two different battery sizes, but the processors themselves are different as well.